LTR Pharma Limited (AU:LTP) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
LTR Pharma Limited is set to capture attention in the financial markets with its new fast-acting nasal spray treatment for erectile dysfunction, targeting sophisticated investors across multiple countries. The company is actively engaging with institutional accredited investors for capital raising opportunities.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue